PANITUMUMAB vs PARICALCITOL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PANITUMUMAB vs PARICALCITOL: Safety Overview
| Metric | PANITUMUMAB | PARICALCITOL |
|---|---|---|
| Total FAERS Reports | 10,876 | 6,665 |
| Deaths Reported | 1,666 | 4,801 |
| Death Rate | 15.3% | 72.0% |
| Hospitalizations | 3,121 | 1,662 |
| Average Patient Age | 63.0 yrs | 57.8 yrs |
| % Female Patients | 36.9% | 43.1% |
| FDA Approval Date | N/A | Apr 17, 1998 |
| Manufacturer | Amgen Inc | Aurobindo Pharma Limited |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |